The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.
Health
·
Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
CN
CitrixNews Staff
Originally reported by New York Times
Related Articles
Health
Trump to undergo annual physical after year of public attention to health issues
US president, who turns 80 next month, frequently casts himself as fit but recent photos have added to questions about h...
CitrixNews Staff
·
2 hours ago
Health
I lost my beloved husband after 35 years, then my sister and my father. Here’s how I rebuilt my old happy self
I tried everything from gong baths to junk food and intermittent crying as I attempted to deal with my grief. Nothing he...
CitrixNews Staff
·
5 hours ago
Health
Scientists create wearable ultrasound to continuously monitor babies in womb
Team hope the UPatch – at present a proof-of-concept device – will aid early detection of complications and prevent stil...
CitrixNews Staff
·
5 hours ago
Health
Therapists are using AI to take notes. Is it a useful tool or a breach of trust?
Mental Health Therapists are using AI to take notes. Is it a useful tool or a breach of trust? May 26, 20265:00 AM ET...
CitrixNews Staff
·
5 hours ago